We are taking a short break, but we will be back next week. Stay tuned!
|Bid||78.33 x 1200|
|Ask||78.43 x 1100|
|Day's Range||77.98 - 79.06|
|52 Week Range||68.44 - 84.56|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||35.67|
|Earnings Date||Oct. 28, 2021|
|Forward Dividend & Yield||2.60 (3.32%)|
|Ex-Dividend Date||Sep. 14, 2021|
|1y Target Est||94.08|
Yahoo Finance’s Alexis Christoforous reports the latest FDA decision on COVID-19 boosters.
Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.
(Bloomberg) -- Johnson & Johnson’s Covid vaccine booster gained a key recommendation from advisers to the U.S. Food and Drug Administration that brings the additional shot a step closer to clearance.Most Read from BloombergOut-of-Practice Airline Pilots Are Making Errors Back in the AirWhy Buying a Second or Even Third Home Is Becoming More Popular Than EverThe World’s Rich and Powerful Are Stashing $500 Billion in This Tax HavenThe Biggest Public Graveyard in the U.S. Is Becoming a ParkWhat Com